24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
cancer
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
09:22
Altshuler Shaham shareholders consider sale of controlling stake
21:46
Israel’s deficit falls to 3.2% of GDP as tax revenues continue to climb
21:40
Israel can absorb a settlement boycott. The bigger risk is what comes next
21:11
IDF to create new branch for AI and autonomous warfare
More stories
Buzz
Most popular
Daily
Weekly
1
What made Anthropic walk away from the $6 billion Decart deal?
2
Anthropic drops plans to acquire Israeli AI startup Decart
3
Palo Alto Networks founder Nir Zuk raises $245 million for new cybersecurity startup
4
Hapag-Lloyd and FIMI to submit improved bid for Zim
5
Israir sells $8 million of New York flights within hours of opening bookings
More news
cancer
2 stories about cancer
Meet Kite Pharma's CEO, the Man Bringing Hope to Hodgkin's Lymphoma Patients
30.08.17
|
Dror Reich
With two exits worth hundreds of millions of dollars to his name even before selling Kite Pharma for $12 billion dollars, just where will Arie Belldegrun aim next?
Gilead To Buy Kite Pharma for $11.9 Billion
29.08.17
|
Dror Reich
The drug company is looking to diversify into cell therapy following declining hepatitis c drug sales
